A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany

被引:0
|
作者
Ralf Birkemeyer
Alfred Müller
Steffen Wahler
Johann-Matthias von der Schulenburg
机构
[1] Ulm Herzklinik,
[2] Analytic Services GmbH,undefined
[3] St. Bernward GmbH,undefined
[4] Universität Hannover,undefined
来源
关键词
Atrial fibrillation; Screening; Prevention of stroke; Cost-effectiveness analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] A cost-effectiveness analysis model of Preventicus atrial fibrillation screening from the point of view of statutory health insurance in Germany
    Birkemeyer, Ralf
    Mueller, Alfred
    Wahler, Steffen
    von der Schulenburg, Johann-Matthias
    HEALTH ECONOMICS REVIEW, 2020, 10 (01)
  • [2] A COST-EFFECTIVENESS MODEL ABOUT ATRIAL FIBRILLATION SCREENING FROM THE PERSPECTIVE OF THE GERMAN STATUTORY HEALTH INSURANCE
    Birkemeyer, R.
    Wahler, S.
    Mueller, A.
    von der Schulenburg, J. M.
    VALUE IN HEALTH, 2020, 23 : S497 - S497
  • [3] Cost-Effectiveness of Ranibizumab for the Treatment of Neovascular Age-Related Macular Degeneration in Germany: Model Analysis From the Perspective of Germany's Statutory Health Insurance System
    Neubauer, Aljoscha S.
    Holz, Frank G.
    Sauer, Stefan
    Wasmuth, Timo
    Hirneiss, Christoph
    Kampik, Anselm
    Schrader, Wolfgang
    CLINICAL THERAPEUTICS, 2010, 32 (07) : 1343 - 1356
  • [4] COST-EFFECTIVENESS ANALYSIS OF ATRIAL FIBRILLATION SCREENING IN THE ELDERLY POPULATION OF TAIWAN
    Fu, Y. H.
    Chao, T. F.
    Yeh, Y. H.
    Chan, Y. H.
    Chien, H. T.
    Lin, F. J.
    Chen, S. A.
    VALUE IN HEALTH, 2022, 25 (12) : S130 - S130
  • [5] Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
    Welton, Nicky J.
    McAleenan, Alexandra
    Thom, Howard H. Z.
    Davies, Philippa
    Hollingworth, Will
    Higgins, Julian P. T.
    Okoli, George
    Sterne, Jonathan A. C.
    Feder, Gene
    Eaton, Diane
    Hingorani, Aroon
    Fawsitt, Christopher
    Lobban, Trudie
    Bryden, Peter
    Richards, Alison
    Sofat, Reecha
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (29) : 1 - +
  • [6] COST-EFFECTIVENESS ANALYSIS OF SCREENING STRATEGIES FOR ATRIAL FIBRILLATION IN ENGLAND AND WALES
    Thom, H.
    Hollingworth, W.
    McAleenan, A.
    Davies, P.
    Higgins, J.
    Okoli, G. N.
    Sterne, J.
    Feder, G.
    Eaton, D.
    Hingorani, A.
    Fawsitt, C.
    Lobban, T.
    Bryden, P. A.
    Richards, A.
    Sofat, R.
    Welton, N. J.
    VALUE IN HEALTH, 2016, 19 (07) : A706 - A707
  • [7] Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis
    Aronsson, Mattias
    Svennberg, Emma
    Rosenqvist, Marten
    Engdahl, Johan
    Al-Khalili, Faris
    Friberg, Leif
    Frykman, Viveka
    Levin, Lars-Ake
    EUROPACE, 2017, 19 (10): : 1650 - 1656
  • [8] A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
    Levin, Lars-Ake
    Husberg, Magnus
    Sobocinski, Piotr Doliwa
    Kull, Viveka Frykman
    Friberg, Leif
    Rosenqvist, Marten
    Davidson, Thomas
    EUROPACE, 2015, 17 (02): : 207 - 214
  • [9] OPORTUNISTIC SCREENING FOR ATRIAL FIBRILLATION IN PRIMARY CARE - A CLINICAL AND COST-EFFECTIVENESS ANALYSIS
    Moran, P.
    Teljeur, C.
    Harrington, P.
    Smith, S.
    Normand, C.
    Ryan, M.
    VALUE IN HEALTH, 2015, 18 (07) : A391 - A391
  • [10] Cost-effectiveness of atrial fibrillation screening in Canadian community practice
    Andrade, Jason G.
    Shah, Anshul
    Godin, Richard
    Lanitis, Tereza
    Kongnakorn, Thitima
    Brown, Lauren
    Dhanda, Devender
    Dhamane, Amol
    Nault, Isabelle
    HEART RHYTHM O2, 2023, 4 (02): : 103 - 110